Mulligan LM - Search Results

1

The expression of RET and its multiple splice forms in developing human kidney.

Ivanchuk SM, Eng C, Cavenee WK, Mulligan LM. Ivanchuk SM, et al. Among authors: mulligan lm. Oncogene. 1997 Apr 17;14(15):1811-8. doi: 10.1038/sj.onc.1201016. Oncogene. 1997. PMID: 9150387

2

Retinoblastoma and p53 gene product expression in breast carcinoma: immunohistochemical analysis and clinicopathologic correlation.

Trudel M, Mulligan L, Cavenee W, Margolese R, Côté J, Gariépy G. Trudel M, et al. Hum Pathol. 1992 Dec;23(12):1388-94. doi: 10.1016/0046-8177(92)90059-c. Hum Pathol. 1992. PMID: 1468776

3

A new polymorphism in the ret protooncogene (RET).

Mulligan LM, Gardner E, Papi L, Ponder BA. Mulligan LM, et al. Nucleic Acids Res. 1991 Oct 25;19(20):5795. doi: 10.1093/nar/19.20.5795. Nucleic Acids Res. 1991. PMID: 1682880 Free PMC article.

4

Expression of growth-related genes in human fetal kidney.

Goodyer PR, Mulligan L, Goodyer CG. Goodyer PR, et al. Am J Kidney Dis. 1991 Jun;17(6):608-10. doi: 10.1016/s0272-6386(12)80331-3. Am J Kidney Dis. 1991. PMID: 2042631

5

Mechanisms of p53 loss in human sarcomas.

Mulligan LM, Matlashewski GJ, Scrable HJ, Cavenee WK. Mulligan LM, et al. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5863-7. doi: 10.1073/pnas.87.15.5863. Proc Natl Acad Sci U S A. 1990. PMID: 2143022 Free PMC article.

6

Characterization of RET proto-oncogene 3' splicing variants and polyadenylation sites: a novel C-terminus for RET.

Myers SM, Eng C, Ponder BA, Mulligan LM. Myers SM, et al. Among authors: mulligan lm. Oncogene. 1995 Nov 16;11(10):2039-45. Oncogene. 1995. PMID: 7478523

7

Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma.

Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HP, Pfragner R, Behmel A, Lorenzo MJ, et al. Eng C, et al. Among authors: mulligan lm. Genes Chromosomes Cancer. 1995 Mar;12(3):209-12. doi: 10.1002/gcc.2870120308. Genes Chromosomes Cancer. 1995. PMID: 7536460

8

Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.

Neumann HP, Eng C, Mulligan LM, Glavac D, Zäuner I, Ponder BA, Crossey PA, Maher ER, Brauch H. Neumann HP, et al. Among authors: mulligan lm. JAMA. 1995 Oct 11;274(14):1149-51. JAMA. 1995. PMID: 7563486

9

Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.

Attié T, Pelet A, Edery P, Eng C, Mulligan LM, Amiel J, Boutrand L, Beldjord C, Nihoul-Fékété C, Munnich A, et al. Attié T, et al. Among authors: mulligan lm. Hum Mol Genet. 1995 Aug;4(8):1381-6. doi: 10.1093/hmg/4.8.1381. Hum Mol Genet. 1995. PMID: 7581377

10

Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.

Mulligan LM, Ponder BA. Mulligan LM, et al. J Clin Endocrinol Metab. 1995 Jul;80(7):1989-95. doi: 10.1210/jcem.80.7.7608246. J Clin Endocrinol Metab. 1995. PMID: 7608246 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters